Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600426.SS Stock Summary
In the News
600426.SS Financial details
Company Rating
Strong Buy
Market Cap
51.51B
Income
3.68B
Revenue
26.58B
Book val./share
13.37
Cash/share
1.06
Dividend
0.8
Dividend %
2.99%
Employees
5.23K
Optionable
No
Shortable
Yes
Earnings
30 Mar 2024
P/E
15.41
Forward P/E
7.23
PEG
-3.12
P/S
2.13
P/B
2.01
P/C
23.86
P/FCF
-11.97
Quick Ratio
1.16
Current Ratio
1.68
Debt / Equity
0.27
LT Debt / Equity
0.24
-
-
EPS (TTM)
1.74
EPS next Y
3.5
EPS next Q
-
EPS this Y
-13.66%
EPS next Y
101.04%
EPS next 5Y
-
EPS last 5Y
15.58%
Revenue last 5Y
16.07%
Revenue Q/Q
10.81%
EPS Q/Q
29.55%
-
-
-
-
SMA20
-7.41%
SMA50
-7.41%
SMA100
-19.35%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
13%
ROC
0.12%
Gross Margin
21%
Oper. Margin
17%
Profit Margin
14%
Payout
52%
Shs Outstand
2.11B
Shs Float
1.41B
-
-
-
-
Target Price
-
52W Range
23.32-36.03
52W High
-29.75%
52W Low
+9.96%
RSI
47
Rel Volume
1.04
Avg Volume
13.28M
Volume
13.8M
Perf Week
1.32%
Perf Month
-2.43%
Perf Quarter
-
Perf Half Y
-22.38%
-
-
-
-
Beta
0.973
-
-
Volatility
0.41%, 0.91%
Prev Close
-0.86%
Price
25.29
Change
1.89%
600426.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.84 | 6.74 | 6.23 | 12.62 | 14.34 | |
Net income per share | 1.44 | 1.16 | 0.85 | 3.45 | 2.98 | |
Operating cash flow per share | 1.88 | 1.77 | 1.42 | 2.33 | 3.32 | |
Free cash flow per share | 1.26 | 0.89 | 0.18 | 0.58 | 0.01 | |
Cash per share | 0.61 | 0.95 | 0.98 | 1.37 | 1.54 | |
Book value per share | 5.75 | 6.76 | 7.34 | 10.55 | 12.76 | |
Tangible book value per share | 5.42 | 6.25 | 6.84 | 10.05 | 12.41 | |
Share holders equity per share | 5.75 | 6.76 | 7.34 | 10.55 | 12.76 | |
Interest debt per share | 2.09 | 1.23 | 1.2 | 1.18 | 1.82 | |
Market cap | 18.57B | 32.2B | 60.44B | 66.04B | 69.94B | |
Enterprise value | 21.49B | 33.9B | 61.79B | 66.54B | 71.84B | |
P/E ratio | 6.15 | 13.12 | 33.61 | 9.08 | 11.12 | |
Price to sales ratio | 1.29 | 2.27 | 4.61 | 2.48 | 2.31 | |
POCF ratio | 4.71 | 8.62 | 20.18 | 13.46 | 9.99 | |
PFCF ratio | 7 | 17.12 | 159.46 | 53.54 | 2.38K | |
P/B Ratio | 1.54 | 2.26 | 3.91 | 2.97 | 2.6 | |
PTB ratio | 1.54 | 2.26 | 3.91 | 2.97 | 2.6 | |
EV to sales | 1.5 | 2.39 | 4.71 | 2.5 | 2.38 | |
Enterprise value over EBITDA | 4.26 | 7.8 | 17.46 | 6.59 | 7.72 | |
EV to operating cash flow | 5.45 | 9.07 | 20.63 | 13.56 | 10.26 | |
EV to free cash flow | 8.1 | 18.03 | 163.04 | 53.95 | 2.45K | |
Earnings yield | 0.16 | 0.08 | 0.03 | 0.11 | 0.09 | |
Free cash flow yield | 0.14 | 0.06 | 0.01 | 0.02 | 0 | |
Debt to equity | 0.35 | 0.17 | 0.16 | 0.11 | 0.14 | |
Debt to assets | 0.23 | 0.13 | 0.12 | 0.08 | 0.11 | |
Net debt to EBITDA | 0.58 | 0.39 | 0.38 | 0.05 | 0.2 | |
Current ratio | 1.09 | 1.43 | 0.88 | 1.99 | 2.4 | |
Interest coverage | 18.87 | 16.8 | 19.68 | 77.64 | 83.48 | |
Income quality | 1.31 | 1.52 | 1.67 | 0.68 | 1.11 | |
Dividend Yield | 0.03 | 0.02 | 0.01 | 0.01 | 0.03 | |
Payout ratio | 0.16 | 0.21 | 0.38 | 0.08 | 0.29 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.02 | 0.02 | 0.01 | 0.02 | |
Intangibles to total assets | 0.04 | 0.06 | 0.06 | 0.05 | 0.05 | |
Capex to operating cash flow | -0.33 | -0.5 | -0.87 | -0.75 | -1 | |
Capex to revenue | -0.09 | -0.13 | -0.2 | -0.14 | -0.23 | |
Capex to depreciation | -1.07 | -1.44 | -2.01 | -2.59 | -3.93 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 13.64 | 13.31 | 11.88 | 28.6 | 29.26 | |
ROIC | 0.19 | 0.15 | 0.1 | 0.29 | 0.21 | |
Return on tangible assets | 0.17 | 0.14 | 0.09 | 0.27 | 0.19 | |
Graham Net | -1.94 | -0.46 | -1.04 | 0.38 | -0.2 | |
Working capital | 339.11M | 1.06B | -447.15M | 4.17B | 5.01B | |
Tangible asset value | 11.37B | 13.16B | 14.41B | 21.21B | 26.18B | |
Net current asset value | -2.27B | -465.42M | -1.63B | 2.44B | 1.5B | |
Invested capital | 0.35 | 0.17 | 0.16 | 0.11 | 0.14 | |
Average receivables | 1.05B | 1.19B | 881.05M | 2.56B | 4.11B | |
Average payables | 1.45B | 1.2B | 1.14B | 1.83B | 1.91B | |
Average inventory | 479.4M | 444.4M | 302.53M | 656M | 1.11B | |
Days sales outstanding | 32.4 | 28.23 | 18.5 | 61.08 | 45.45 | |
Days payables outstanding | 57.34 | 29.37 | 51.62 | 46.57 | 27.58 | |
Days of inventory on hand | 20.38 | 11.82 | 9.68 | 22.06 | 19.92 | |
Receivables turnover | 11.26 | 12.93 | 19.73 | 5.98 | 8.03 | |
Payables turnover | 6.37 | 12.43 | 7.07 | 7.84 | 13.23 | |
Inventory turnover | 17.91 | 30.88 | 37.71 | 16.54 | 18.32 | |
ROE | 0.25 | 0.17 | 0.12 | 0.33 | 0.23 | |
Capex per share | -0.61 | -0.88 | -1.24 | -1.74 | -3.3 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.07 | 3.43 | 2.87 | 2.99 | 3.31 | |
Net income per share | 0.49 | 0.36 | 0.37 | 0.44 | 0.58 | |
Operating cash flow per share | 0.49 | 0.36 | 0.37 | 0.75 | 0.55 | |
Free cash flow per share | -0.46 | -0.76 | -0.42 | -0.55 | -0.52 | |
Cash per share | 2 | 1.54 | 1.65 | 1.17 | 1.06 | |
Book value per share | 12.39 | 12.76 | 13.15 | 12.78 | 13.37 | |
Tangible book value per share | 11.9 | 12.41 | 12.9 | 12.51 | 13.01 | |
Share holders equity per share | 12.39 | 12.76 | 13.15 | 12.78 | 13.37 | |
Interest debt per share | 1.78 | 1.78 | 2.24 | 3.13 | 3.57 | |
Market cap | 61.54B | 69.94B | 74.37B | 64.69B | 67.79B | |
Enterprise value | 62.06B | 71.84B | 76.28B | 69.42B | 73.78B | |
P/E ratio | 15.02 | 23.16 | 23.79 | 17.43 | 13.92 | |
Price to sales ratio | 9.5 | 9.66 | 12.29 | 10.26 | 9.7 | |
POCF ratio | 60.07 | 92.62 | 95.15 | 41.02 | 58.9 | |
PFCF ratio | -63.96 | -43.69 | -84.54 | -56.2 | -62.22 | |
P/B Ratio | 2.35 | 2.6 | 2.68 | 2.4 | 2.4 | |
PTB ratio | 2.35 | 2.6 | 2.68 | 2.4 | 2.4 | |
EV to sales | 9.58 | 9.93 | 12.6 | 11.01 | 10.56 | |
Enterprise value over EBITDA | 51.54 | 76.24 | 80.89 | 62.96 | 51.49 | |
EV to operating cash flow | 60.57 | 95.14 | 97.59 | 44.02 | 64.1 | |
EV to free cash flow | -64.49 | -44.88 | -86.72 | -60.31 | -67.71 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Free cash flow yield | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | |
Debt to equity | 0.14 | 0.14 | 0.17 | 0.24 | 0.27 | |
Debt to assets | 0.11 | 0.11 | 0.13 | 0.17 | 0.18 | |
Net debt to EBITDA | 0.43 | 2.01 | 2.03 | 4.29 | 4.18 | |
Current ratio | 2.66 | 2.4 | 2.17 | 1.64 | 1.68 | |
Interest coverage | 99.37 | 74.87 | 44.63 | 51.82 | 59.79 | |
Income quality | 1 | 1 | 1 | 1.7 | 0.95 | |
Dividend Yield | 0 | 0 | 0 | 0.03 | 0 | |
Payout ratio | 0.03 | 0.04 | 0.06 | 1.89 | 0.06 | |
Sales general and administrative to revenue | 0.03 | -0.03 | 0.01 | 0 | 0.02 | |
Research and developement to revenue | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -1.94 | -3.12 | -2.13 | -1.73 | -1.95 | |
Capex to revenue | -0.31 | -0.33 | -0.27 | -0.43 | -0.32 | |
Capex to depreciation | -4.47 | -5.31 | -3.68 | -6.04 | 2.49 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0.01 | 0 | |
Graham number | 11.64 | 10.14 | 10.47 | 11.24 | 13.17 | |
ROIC | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | |
Return on tangible assets | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | |
Graham Net | 0.48 | -0.2 | -0.88 | -2.75 | -3.14 | |
Working capital | 5.91B | 5.01B | 4.69B | 2.77B | 3.07B | |
Tangible asset value | 25.11B | 26.18B | 27.21B | 26.41B | 27.48B | |
Net current asset value | 2.69B | 1.5B | 321.6M | -3.6B | -4.1B | |
Invested capital | 0.14 | 0.14 | 0.17 | 0.24 | 0.27 | |
Average receivables | 4.44B | 3.93B | 3.52B | 2.87B | 2.71B | |
Average payables | 1.52B | 1.49B | 1.98B | 2.53B | 2.61B | |
Average inventory | 1.03B | 1.09B | 1.18B | 1.18B | 1.17B | |
Days sales outstanding | 56.81 | 46.84 | 48.8 | 35.15 | 38.01 | |
Days payables outstanding | 24.47 | 24.84 | 43.46 | 49.5 | 42.4 | |
Days of inventory on hand | 18.19 | 17.94 | 22.16 | 21.13 | 19.88 | |
Receivables turnover | 1.58 | 1.92 | 1.84 | 2.56 | 2.37 | |
Payables turnover | 3.68 | 3.62 | 2.07 | 1.82 | 2.12 | |
Inventory turnover | 4.95 | 5.02 | 4.06 | 4.26 | 4.53 | |
ROE | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | |
Capex per share | -0.94 | -1.12 | -0.79 | -1.29 | -1.06 |
600426.SS Frequently Asked Questions
What is Shandong Hualu-Hengsheng Chemical Co., Ltd. stock symbol ?
Shandong Hualu-Hengsheng Chemical Co., Ltd. is a CN stock and trading under the symbol 600426.SS
What is Shandong Hualu-Hengsheng Chemical Co., Ltd. stock quote today ?
Shandong Hualu-Hengsheng Chemical Co., Ltd. stock price is $25.29 today.
Is Shandong Hualu-Hengsheng Chemical Co., Ltd. stock public?
Yes, Shandong Hualu-Hengsheng Chemical Co., Ltd. is a publicly traded company.